冠心病合并微量清蛋白尿与心血管事件的相关研究

目的：探讨冠心病合并微量清蛋白尿(MAU)与心血管事件的相关性。方法连续选择该院冠心病患者共120例,根据尿清蛋白肌酐比值(UACR)分为观察组(30 mg/g< UACR<300 mg/g,n=80)和对照组(UACR≤30 mg/g,n=40),随访15个月后比较分析两组患者心血管事件与 MAU 水平的相关性。结果观察组的 MAU 水平显著高于对照组,差异有统计学意义(P <0.05)。观察组患者的心血管事件共发生163次,对照组57次,观察组的心血管事件发生率显著高于对照组,差异有统计学意义(t=3.717,P <0.05)。Spearman 相关分析可知,MAU 与心血管事件呈显著正相关(r =0.721,P <0.01)。影响因素有MAU(P =0.001)、C 反应蛋白(P =0.037)。结论MAU 浓度与冠心病患者心血管事件密切相关,可以预测心血管事件的发生。

Correlation between microalbuminuria and cardiovascular events in patients with coronary heart disease

Objective To investigate the correlation between microalbuminuria and cardiovascular events in patients with coronary heart disease.Methods A total of 120 CHD patients were divided into experiment group (30 mg/g< UACR<300 mg/g, n=80)and control group(UACR≤30 mg/g,n=40)The relationship between MAU and cardiovascular events rate was compared after 1 5 months.Results Microalbuminuria level in experiment group was significantly higher than control group(P <0.05).The incidence of cardiovascular event in experiment group was significantly higher(t = 3.71 7,P <0.05 ).MAU and cardiovascular e-vents were positively related by Spearman′s analysis(r=0.721,P <0.01).The effective factors were MAU and CRP(MAU:P =0.001;CRP:P =0.037).Conclusion MAU concentration had a great impact on the incidence of cardiovascular event.The incidence of cardiovascular might be predicted by the MAU.